Climate Change Data

Aspen Pharmacare Holdings Limited

Climate Impact & Sustainability Data (2013, 2015, 2017, 2018, 2020-07 to 2021-06, 2021, 2022, 2023)

Reporting Period: 2013

Environmental Metrics

ESG Focus Areas

  • Occupational health, safety, and environment management
  • Corporate social responsibility
  • BBBEE (Broad-Based Black Economic Empowerment)
  • Sustainability

Environmental Achievements

  • South African sites achieved ISO 14001 and OHSAS 18001 certifications.
  • Aspen Bad Oldesloe site maintained ISO 14001 and OHSAS 18001 certification.

Social Achievements

  • Nelson Mandela International Day reached approximately 9,400 beneficiaries.
  • Aspen played a leading role in forming the Public Healthcare Enhancement Fund in South Africa.
  • Aspen became an active participant in the United Nations Global Compact.

Governance Achievements

  • Aspen’s Sustainability Report was externally assured for the first time.
  • Further incremental enhancements were made to the Group’s governance processes, including the appointment of Regional Ethics Officers.

Climate Goals & Targets

Environmental Challenges

  • Intense competition in the global pharmaceutical market.
  • Stringent regulation and application of quality standards.
  • Market diversity increasing variability of customer expectations and supply chain complexities.
  • Delayed approval of API source changes.
  • Evolving regulatory requirements and product regulations.
  • Advent of the Falsified Medicines Directive in Europe.
  • Publication of European Union distribution guidelines.
  • Divergent Human Resource practices and SHE standards throughout the Group.
  • Lack of an integrated Human Resources Management System.
  • Onerous reporting and disclosure requirements in respect of Aspen’s corporate citizenship.
  • Acquired businesses come with their own organizational cultures requiring alignment with Aspen’s culture.
  • Completion of proposed transactions subject to conditions precedent, including approval of various competition authorities.
  • Revised Department of Trade & Industry’s BBBEE Codes may lead to a less favorable BBBEE rating.
Mitigation Strategies
  • Various transactions to increase product offering and geographic coverage.
  • Group supply chain head appointed to review and manage efficiency and integrity of the global supply chain.
  • Group supply chain portal commissioned for enhanced communication.
  • Group Quality Department established to monitor and manage quality risk.
  • Remediation plans implemented to prevent recurrence of product recalls.
  • Proactive material sourcing.
  • Approximately 400 specialist sales personnel to transfer to Aspen for direct promotion of products.
  • Over 300 new commercial employees to support acquired infant nutritional business.
  • Sales teams in Brazil, Mexico, and Venezuela to be increased.
  • Direct promotion of Aspen’s products increased in several markets.
  • Development centre established in India to enhance capacity to maintain intellectual property cost-effectively.
  • Supply chain automation project to improve supply chain efficiencies.
  • Addressing divergent Human Resource practices and SHE standards.
  • Change management programs to assist in the integration of acquired businesses.
  • Embedding principles of good corporate governance in business practices.
  • Mandela Day initiative retained as an annual event.
  • Building infrastructure and resources ahead of completion of proposed transactions.
  • Divestiture of non-core products/businesses to be considered.

Supply Chain Management

Responsible Procurement
  • Centralised procurement leading to benefits in sourcing raw materials and products

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI (Global Reporting Initiative) B+ application level, King III

Certifications: ISO 14001, OHSAS 18001, ISO 22000, HACCP

Third-party Assurance: Environmental Resources Management, PricewaterhouseCoopers Inc.

Awards & Recognition

  • Best generics manufacturer (Soweto General Practitioner Confidence Predictor survey)
  • Generic Supplier of the Year (Sigma Supplier Awards)
  • Supplier of the Year 2013 Award (Discount Drug Store)
  • Generic Supplier of the Year Award (Inaugural Sigma Supplier Awards)
  • Kidspot Best Baby Formula award (Australian parents)
  • President’s Manufacturer of the Year Award (Tanzania)
  • Golden Arrow Award (PMR.africa)
  • Ireland INC Foreign Direct Investment 100 honorees
  • Supplier of the Year award (Dis-Chem)
  • Best Corporate Web Page (Aspid Award)

Reporting Period: 2015

Environmental Metrics

Total Carbon Emissions:190,000 tCO2e (Scope 1 and 2 combined, excluding Aspen API)
Scope 1 Emissions:38,036 tCO2e
Scope 2 Emissions:151,183 tCO2e
Scope 3 Emissions:Not disclosed
Renewable Energy Share:100% at Aspen Bad Oldesloe
Total Energy Consumption:696,437 GJ
Water Consumption:1,715,642 kℓ
Waste Generated:52,502 tons
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Sustaining life and health through high-quality, affordable medicines
  • Adding economic value to stakeholders
  • Maintenance of financial health
  • Sustaining a cost-competitive manufacturing base
  • Providing a safe working environment
  • Promoting equality
  • Creating an environment in which our employees can thrive
  • Contributing to the enhancement of healthcare, education and basic needs in communities
  • Preserving the environment
  • Managing the efficient utilisation of scarce resources
  • Conducting our business in a responsible manner

Environmental Achievements

  • Aspen Bad Oldesloe uses 100% renewable energy
  • Improved waste recycling (883% increase, largely due to inclusion of new facilities)

Social Achievements

  • Supported 263 socio-economic development (SED) projects valued at R20.5 million
  • Launched Women in Leadership Programme
  • Launched dairyman learnership programme including learners with disabilities
  • Increased investment in employee training (63% increase)

Governance Achievements

  • Continued compliance with JSE’s SRI index
  • Executive compensation linked to financial, social, environmental, and governance aspects

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Implementation of intensity-based measures for material KPIs
  • Expand scope of Aspen’s CDP carbon and water submissions
  • Setting targets for material KPIs
Short-term Goals:
  • Complete OHSAS 18001 alignment project by 2017
  • Align environmental management systems at other manufacturing sites to ISO 14001 by 2017

Environmental Challenges

  • Increased global economic pressure (volatile currency markets, price reductions, heightened regulation)
  • Aging infrastructure at Moleneind and Boxtel sites in the Netherlands leading to safety and environmental compliance risks
  • Soil contamination at Moleneind site (responsibility retained by previous owner, MSD)
  • Spills at Moleneind site
  • Changes to BBBEE Codes in South Africa impacting scorecard
  • High staff turnover in some regions
  • Electricity shortages in South Africa impacting manufacturing
  • Water scarcity and aging infrastructure impacting water supply consistency
Mitigation Strategies
  • Capital expansion projects in South Africa, France, and the Netherlands to improve supply chain and reduce costs
  • Divestment of non-core brands and molecules
  • Implementation of formal SHE management systems
  • Proactive engagement with stakeholders and authorities in the Netherlands
  • Revised transformational objectives and programs in South Africa to address BBBEE Code changes
  • Interventions to address high staff turnover rates
  • Energy conservation initiatives (e.g., LED lighting, SCADA system)
  • Water conservation initiatives (e.g., water recycling, leak prevention)

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Procurement from accredited and authorized suppliers meeting quality, regulatory, and Aspen-specified requirements
  • Suppliers bound by Aspen’s Code of Conduct

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: GRI G3.0, JSE’s Socially Responsible Investment (SRI) index, International Integrated Reporting Council’s Framework, UN Global Compact

Certifications: OHSAS 18001 (selected sites), ISO 14001 (selected sites), ISO 50001 (Aspen Bad Oldesloe)

Third-party Assurance: Environmental Resources Management (Pty) Limited (ERM), PricewaterhouseCoopers Inc. (PwC)

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2017

Environmental Metrics

Total Carbon Emissions:208672 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:48435 tCO2e/year
Scope 2 Emissions:160237 tCO2e/year
Total Energy Consumption:692449 GJ/year
Water Consumption:1634966 kℓ/year
Waste Generated:76577 tons/year

ESG Focus Areas

  • Access to high quality, affordable medicines
  • Integrated supply chain
  • Employee well-being
  • Corporate citizenship
  • Sustainable economic value

Environmental Achievements

  • 4.5% of waste generated sent to landfill, a reduction from 6.2% in 2016
  • An estimated 97,000 kℓ of water saved through resource efficiency projects
  • 8% increase in waste recycled

Social Achievements

  • 84% participation rate in the global employee engagement survey
  • R49.5 million invested in employee training
  • 49% women in the workforce
  • Zero work-related fatalities
  • Maintained Level 4 BBBEE rating in South Africa
  • More than 250 SED projects completed

Governance Achievements

  • New Group Code of Marketing Practice rolled out
  • 9,242 employees signed the Aspen Code of Conduct
  • Improved rating on the JSE/FTSE Responsible Investment Index

Climate Goals & Targets

Environmental Challenges

  • Pricing of oncology products under scrutiny
  • Currency headwinds, price erosion, and constrained nutritionals sales
  • Supply chain constraints
  • Competition from biosimilars, generics, and oral products
  • Challenges in transitioning the manufacture of Thyrax
  • Changes in European distribution model
  • Loss of Venezuelan volumes and Chinese regulatory restrictions on sales from Australia
  • Increased scrutiny on pricing from competition authorities
  • Supply shortages of mature products
  • Evolving pharmaceutical regulations and stringent quality standards
  • Competition in the global pharmaceutical market
  • Volatile geopolitical and economic conditions
  • Complexity of integrating acquired businesses
  • Challenges in the Chinese market
Mitigation Strategies
  • Proactive engagement with authorities in investigations
  • Synergy projects to offset headwinds
  • Focus on manufacturing efficiency and working capital management
  • Strategic advantage from vertically integrated supply chain
  • Progress in stabilizing API production of synthetic estrogens
  • Improved supply chain in Latin America
  • Reshaping portfolio in Australia to focus on value-adding brands
  • Increased capacity in manufacturing facilities
  • Upgrading older medicines to meet modern regulatory requirements
  • Product and geographic diversification
  • Focus on niche speciality pharmaceuticals
  • Strong corporate governance, high ethical standards, and stakeholder-inclusive approach
  • Initiatives to streamline global product portfolio
  • New global HR strategy
  • Continued investment in skills development
  • Phased approach to ISO certification
  • Reduction in chemical activity at Moleneind facility in Oss
  • Full cooperation with competition authorities
  • Continued investment in manufacturing capacity
  • Focus on cost containment initiatives
  • Strategic initiatives to diversify market risks, currency risks, and product risks
  • Leveraging existing sales force and sterile manufacturing capabilities
  • Strategic review of Nutritionals business
  • Leveraging HPC launch in the USA and synthetic estrogen launch

Supply Chain Management

Responsible Procurement
  • Aspen Supplier Code of Conduct
  • Ethical and human rights standards

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI, King IV

Certifications: OHSAS 18001 (75% of primary manufacturing facilities and 29% of API facilities), ISO 14001 (75% of primary manufacturing facilities and 29% of API facilities)

Third-party Assurance: ERM, PwC, Group Internal Audit, Empowerdex

Reporting Period: 2018

Environmental Metrics

Total Carbon Emissions:44,305 tCO2e (Scope 1); 148,912 tCO2e (Scope 2) (2018)
Scope 1 Emissions:44,305 tCO2e (2018)
Scope 2 Emissions:148,912 tCO2e (2018)
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:663,557 GJ (2018)
Water Consumption:1,584 Mℓ (2018)
Waste Generated:99,795 tons (2018)
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Sustaining life and health through high quality, affordable medicines
  • Sustaining a cost-competitive manufacturing base
  • Creating an environment in which our employees can thrive
  • Promoting equality
  • Conducting our business in a responsible manner
  • Preserving the environment
  • Adding economic value to stakeholders

Environmental Achievements

  • Reduced carbon emissions (Specific figures not readily available in the provided text, further data needed)
  • Recycled 80,973 tonnes of waste (2018)

Social Achievements

  • BBBEE accreditation Level 4 in South Africa (2018)
  • Socio-economic development (SED) spend of R19.0 million (2018)

Governance Achievements

  • Number of significant legislative infringements: 0 (2018)
  • FTSE/JSE Responsible Investment Index score: 4.0 (2018)

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Not disclosed
Mitigation Strategies
  • Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: International Integrated Reporting Framework, GRI, King IV, Companies Act of South Africa, Department of Trade and Industry’s BBBEE Codes of Good Practice, FTSE/JSE Responsible Investment Index, Carbon and Water Security Disclosure Projects, UN Global Compact

Certifications: Null

Third-party Assurance: Environmental Resources Management (Pty) Limited (ERM), Empowerdex, PricewaterhouseCoopers (PwC)

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2020-07 to 2021-06

Environmental Metrics

Total Carbon Emissions:187670 tCO2e/year
Scope 1 Emissions:44544 tCO2e/year
Scope 2 Emissions:143126 tCO2e/year
Scope 3 Emissions:26340 tCO2e/year
Renewable Energy Share:Not disclosed
Total Energy Consumption:331528 MWh/year
Water Consumption:Not disclosed
Waste Generated:64158.82 tons/year
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Climate Change
  • Water Security

Environmental Achievements

  • Reduced Scope 3 emissions from water supply services by 9%
  • Reduced Scope 3 emissions from fuel-and-energy-related activities by 6%
  • Reduced Scope 3 emissions from waste generated in operations significantly due to correction of a conversion error
  • Reduced Scope 3 emissions from business travel significantly due to travel restrictions during the COVID-19 pandemic
  • Reduced Scope 3 emissions from upstream leased assets by 22%
  • A slight reduction of 1% in total waste generated

Social Achievements

  • Not disclosed

Governance Achievements

  • Board-level oversight of climate-related issues
  • Establishment of a Group Risk and Sustainability function
  • Development of a sustainability materiality assessment survey

Climate Goals & Targets

Long-term Goals:
  • Implement a ten-year Group target for emissions reduction (review in 2023)
Medium-term Goals:
  • Achieve a moderate reduction in Scope 1 and Scope 2 emissions within the next 5 years
  • Develop a clear position statement, absolute targets for emissions reduction, and a climate action strategy within the next two years
Short-term Goals:
  • Introduce an emissions target within the next two years
  • Develop a transition plan within two years
  • Conduct scenario analysis within the next two years

Environmental Challenges

  • Increased indirect (operating) costs due to carbon pricing mechanisms in South Africa
  • Increased capital expenditures due to the phase-out of refrigerants with high global warming potential
  • Decreased access to capital due to increased stakeholder concern and negative stakeholder feedback
Mitigation Strategies
  • Remaining abreast of legislative changes and implementing monitoring and control measures to minimize GHG emissions
  • Replacing existing units with new units that use alternative refrigerants or converting existing units
  • Developing a clear position statement, absolute targets for emissions reduction, and a climate action strategy

Supply Chain Management

Supplier Audits: 0%

Responsible Procurement
  • Aspen Code of Conduct for Suppliers and Service Providers

Climate-Related Risks & Opportunities

Physical Risks
  • Reduced precipitation and rising temperatures impacting water supply and security
Transition Risks
  • Introduction of a carbon pricing system in South Africa and other jurisdictions
  • Future potential requirements for carbon labelling
Opportunities
  • Use of more efficient production and distribution processes
  • Use of supportive policy incentives (e.g., tax refunds in Germany)
  • Use of lower-emission sources of energy (e.g., solar energy)

Reporting Standards

Frameworks Used: TCFD, GHG Protocol

Certifications: ISO 14001, ISO 50001

Third-party Assurance: Aspen SD Assurance Statement 2021.pdf

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2021

Environmental Metrics

ESG Focus Areas

  • Safety
  • Environmental
  • Social
  • Governance

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: AA1000AP (2018), UN Global Compact, OECD Guidelines, SASB, UN SDGs

Third-party Assurance: IBIS Environmental Social Governance Consulting Africa (Pty) Ltd

UN Sustainable Development Goals

  • Eight of the SDGs that most closely align with Aspen’s business have been adopted and reported on for FY2021

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:151,263 tCO2e/year
Scope 1 Emissions:40,082 tCO2e/year
Scope 2 Emissions:111,181 tCO2e/year
Total Energy Consumption:1,071,532 GJ/year
Water Consumption:1,039 megalitres/year
Waste Generated:74,277 tons/year

ESG Focus Areas

  • Access to medicines
  • Health security
  • Patient safety
  • Responsible advocacy and lobbying
  • Responsible marketing
  • Reliable supply of quality products
  • Responsible product portfolio
  • Diversity, equity and inclusion
  • Employee health and safety
  • Employee well-being
  • Fair compensation
  • Labour rights
  • Workforce development
  • Human rights
  • Ethical business culture
  • Compliance
  • Corporate governance
  • Transformation and economic inclusion (B-BBEE in South Africa)
  • SED and investment in communities
  • Economic value generated and distributed
  • Fair taxation
  • Responsible supply chain management
  • Data privacy and information security
  • Climate change and greenhouse gas emissions
  • Energy efficiency
  • Waste
  • Water and effluent

Environmental Achievements

  • 10% reduction in Scope 1 emissions
  • 22% reduction in Scope 2 emissions
  • 5% reduction in water withdrawn
  • 80% of waste generated recycled

Social Achievements

  • Women in top management roles increased to 34%
  • R27.9 million invested in 355 socio-economic development projects
  • Zero occupational fatalities since 2013
  • Global employee engagement survey conducted with 68% response rate

Governance Achievements

  • Strengthened Group Ethics and Compliance programme
  • “B- Management” performance rating for 2021 Carbon Disclosure Project for Climate Change (“CDP-CC”) and “B Management” Carbon Disclosure Project for Water Security (“CDP-WS”)

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Achieve the transfer of the manufacture of complex, sterile products to Aspen sites
  • Further progress on Group human capital strategy
  • Develop a climate change strategy
Short-term Goals:
  • Develop and implement an access to medicines strategy
  • Secure sterile capacity fill opportunities by the end of FY2023

Environmental Challenges

  • Supply chain disruptions due to COVID-19 and the fire at Alphamed facility
  • Geopolitical situation in Russia/Ukraine
  • Renewed lockdown in China impacting product demand
  • Inflationary pressures and downward pressure on selling prices
  • Evolving pharmaceutical regulations and stringent quality standards
Mitigation Strategies
  • Strategic investment in inventory to mitigate supply risks
  • Strong cost management controls
  • Diversified product portfolio and geographical footprint
  • Implementation of integrated business planning process
  • Investment in sterile manufacturing capacity

Supply Chain Management

Responsible Procurement
  • Aspen Code of Conduct for Suppliers and Service Providers
  • Preferential procurement for B-BBEE recognized suppliers

Climate-Related Risks & Opportunities

Physical Risks
  • Natural disasters
  • Water scarcity
Transition Risks
  • Changes in regulations to accelerate climate action
Opportunities
  • Reduce carbon footprint
  • Increase efficiencies in using scarce natural resources
  • Build resilience against physical impacts

Reporting Standards

Frameworks Used: IFRS, IFRS Foundation International Framework, King IV Report on Corporate Governance™, JSE Listings Requirements, GRI Sustainability Reporting Standards, SASB, TCFD, JSE’s Sustainability Disclosure Guidance, UN Global Compact

Certifications: ISO 14001:2015, ISO 45001

Third-party Assurance: Ernst & Young Inc, IBIS Environmental Social Governance Consulting Africa (Pty) Ltd, Empowerdex, Internal Audit

UN Sustainable Development Goals

  • SDG 3
  • SDG 5
  • SDG 6
  • SDG 7
  • SDG 8
  • SDG 12
  • SDG 13
  • SDG 17

Aspen's initiatives contribute to these goals through actions aligned with material sustainability topics.

Sustainable Products & Innovation

  • Eikance eye drops

Awards & Recognition

  • 9th place in EY Excellence in Integrated Reporting Awards
  • Transparency and Reporting Award in South African WEP Awards
  • Finalist in Inclusive Workplace category in South African WEP Awards
  • Economic Diplomacy (Global) Ubuntu Award
  • Top Graduate Employer for the Pharmaceutical Sector in BP Students’ Choice Awards
  • PMR.Africa Diamond Award
  • President’s Manufacturer of the Year Award 2020
  • Best on Corporate Sustainability Initiatives in Social Impact/CSR awards 2021
  • Marketing Excellence Award

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:149,301 tCO2e/year
Scope 1 Emissions:37,424 tCO2e/year
Scope 2 Emissions:111,877 tCO2e/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:1,108,629 GJ/year
Water Consumption:1,061 Mℓ/year
Waste Generated:70,991 tons/year
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Access to medicines
  • Health security
  • Patient safety
  • Reliable supply of quality products
  • Responsible advocacy
  • Responsible marketing
  • Responsible product portfolio
  • Diversity, equity and inclusion
  • Employee health and safety
  • Employee well-being
  • Fair compensation
  • Labour rights
  • Workforce development
  • Compliance
  • Corporate governance
  • Data governance
  • Economic value generated and distributed
  • Ethical business culture
  • Fair taxation
  • Human rights
  • Responsible supply chain management
  • SED and investment in communities
  • Transformation and economic inclusion (B-BBEE in South Africa)
  • Climate change and greenhouse gas emissions
  • Energy efficiency
  • Resource use and waste
  • Water and effluent
  • Responsible advocacy
  • Responsible supply chain management
  • Biodiversity and abundance
  • Health system strengthening
  • Pharmaceuticals in the environment
  • Product environmental stewardship
  • Animal welfare
  • Clinical trial conduct

Environmental Achievements

  • Reduced Scope 1 emissions from 48,095 tCO2e in 2019 to 37,424 tCO2e in 2023
  • Increased waste recycled from 58,821 tonnes in 2020 to 60,976 tonnes in 2023
  • Achieved 86% waste recycled as a percentage of waste generated in 2023

Social Achievements

  • Launched various SED projects supporting clinics, community upliftment, education and training, healthcare, and Mandela Day initiatives.
  • Maintained a relatively stable average staff turnover rate around 14%.

Governance Achievements

  • Maintained high governance and ethical standards, reflected in a FTSE/JSE Responsible Investment Index score of 3.6 in 2023.
  • Incorporated sustainability KPIs into performance and incentive schemes.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Increased pricing of GHG emissions leading to increased operating costs.
  • Increased stakeholder concern or negative feedback potentially reducing capital availability and revenue.
  • Limited emission data on the supply chain (Scope 3 emissions).
Mitigation Strategies
  • Climate scenario analysis conducted to understand potential cost impacts of carbon pricing.
  • Development of a position statement on climate change and a climate strategy with short, medium, and long-term goals.
  • Initiation of a supplier sustainability assessment program to develop a comprehensive Scope 3 emission profile.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Flooding
  • Increased prevalence of vector-borne diseases
Transition Risks
  • Increased pricing of GHG emissions
  • Increased stakeholder concern
  • Limited Scope 3 emission data
Opportunities
  • Energy efficiency improvements
  • Resource conservation

Reporting Standards

Frameworks Used: GRI, SASB, TCFD, UNGC, JSE Sustainability Disclosure Guidance

Certifications: ISO 14001, ISO 45001, ISO 50001

Third-party Assurance: IBIS Environmental Social Governance Consulting Africa Proprietary Limited

UN Sustainable Development Goals

  • SDG 3

Aspen's commitment to promoting access to high-quality, affordable medicines aligns with SDG 3: Ensuring healthy lives and promoting well-being for all at all ages.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed